[Purine metabolism: determination of adenyl deaminase in human lymphocytes]. 1990

A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
Istituto di Chimica Biologica, Università di Siena.

Adenylic acid (AMP) deaminase is a "catabolic enzyme" involved in nucleotide degradation, transforming AMP into inosinic acid (IMP). We present a simple method for the determination of the enzyme activity, which combines high sensitivity with requirement of low quantities of lymphocytes. Human lymphocytes were isolated with a Lymphocyte Separation Medium from FLOW and sonicated. After centrifugation at 2,000 rpm x 10 min and treatment with Norit A, the cells were incubated at 37 degrees C with ATP 0.8 mM and 14C-AMP 0.1 mM (specific activity 12 microCi/mumole) in potassium phosphate 100 mM (pH 7.4). 14C-IMP and 14C-AMP were separated through HPLC by an isocratic elution, with 20 mM KH2PO4 (pH 5.5) at a 1.5 ml/min flow rate. Identification of the nucleotides was carried out through retention time, coelution with internal standards: their evaluation by determining the radioactivity of the collected peaks. The enzyme activity is decreased in patients affected by CLL: the decrease is evident only when data are referred to the single cells and not when they are referred to the protein.

UI MeSH Term Description Entries
D007291 Inosine Monophosphate Inosine 5'-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. IMP,Inosinic Acid,Ribosylhypoxanthine Monophosphate,Inosinic Acids,Sodium Inosinate,Acid, Inosinic,Acids, Inosinic,Inosinate, Sodium,Monophosphate, Inosine,Monophosphate, Ribosylhypoxanthine
D007292 Inosine Nucleotides Inosine Phosphates,Nucleotides, Inosine,Phosphates, Inosine
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009709 Nucleotide Deaminases Catalyze the hydrolysis of nucleotides with the elimination of ammonia. Deaminases, Nucleotide
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000659 AMP Deaminase An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6. AMP Aminase,Adenylate Deaminase,5'-AMP Deaminase,AMP Aminohydrolase,Myoadenylate Deaminase,5' AMP Deaminase,Aminase, AMP,Aminohydrolase, AMP,Deaminase, 5'-AMP,Deaminase, AMP,Deaminase, Adenylate,Deaminase, Myoadenylate
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma

Related Publications

A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
June 1979, Blut,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
January 1978, Ciba Foundation symposium,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
August 1976, Proceedings of the National Academy of Sciences of the United States of America,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
January 1980, Journal of immunological methods,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
July 1977, The Journal of pediatrics,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
July 1984, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
January 1984, International journal of tissue reactions,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
August 1991, Biochemical Society transactions,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
October 1987, Archives of biochemistry and biophysics,
A Tabucchi, and L Terzuoli, and A Di Stefano, and M Pizzichini, and R Leoncini, and E Dispensa, and E Marinello
October 1983, The Journal of biological chemistry,
Copied contents to your clipboard!